# A Study of JNJ-64530440 in Healthy Japanese Male Participants

> **NCT03915886** · PHASE1 · TERMINATED · sponsor: **Janssen Pharmaceutical K.K.** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-0440
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03915886
- **Lead sponsor:** Janssen Pharmaceutical K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-15
- **Primary completion:** 2019-07-17
- **Final completion:** 2019-07-17
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Stopped due to a strategic decision.
- **Last updated:** 2025-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03915886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03915886, "A Study of JNJ-64530440 in Healthy Japanese Male Participants". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT03915886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*